- Cush JJ. Rheumatoid arthritis: early diagnosis and treatment. Med Clin North Am. 2021;105(2):355–365. doi:10.1016/j.mcna.2020.10.006.
- Wasserman A. Rheumatoid arthritis: common questions about diagnosis and management. Am Fam Phys. 2018;97(7):455–462.
- Fraenkel L, Bathon J, England B, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924–939. doi:10.1002/acr.24596.
- Bajaj P, Kollipara U, Koganti R, et al. Coupled effect of electronic medical record modifications and lean six sigma methodology on rheumatoid arthritis disease activity measurement and treat-to-target outcomes. ACR Open Rheumatol. 2021;3(3):164–172. doi:10.1002/acr2.11233.
- Ferucci E, Day G, Choromanski T, et al. Outcomes and quality of care in rheumatoid arthritis with or without telemedicine follow-up visits. Arthritis Care Res (Hoboken). 2022;74(3):484–492. doi:10.1002/acr/24485
- Pincus T, Yazici Y, Bergman M. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009;35(4):773–778, viii. doi:10.1016/j.rdc.2009.10.008.
- Tran K, Duong L. Technology-enabled specialty pharmacy utilization of the routine assessment of patient index data 3 (RAPID3) to monitor and enhance outcomes of rheumatoid arthritis (RA) patients—a retrospective review. J Drug Assess. 2018;7(sup1):28–28. doi:10.1080/21556660.2018.1521104.
- Patel S, Fransen T. Evaluating the Benefit of a Clinically-Integrated Health System Specialty Pharmacy Care Model in Treating Rheumatologic Diseases. Atlanta, GA: Trellis, RX; 2021.
- Freeman JR. Facts: what are the latest statistics on rheumatoid arthritis? Rheumatoid Arthritis Support Network; 2018. https://www.rheumatoidarthritis.org/ra/facts-and-statistics/.
Impact of specialty pharmacy collaboration with rheumatology clinics to improve the achievement of treat-to-target goals in patients with rheumatoid arthritis: a pilot study
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.